Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Lâle Tokgözoğlu

16 ta ish

Hacettepe University

AkademScholarda batafsil koʻrsatkichlar

  1. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L.J. Visseren, François Mach, Yvo M. Smulders +97

    MaqolaOchiq kirish20219 iqtibos
    ABI

  2. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    Alberico L. Catapano, Ian Graham, Guy De Backer +15

    MaqolaOchiq kirish20166 iqtibos
    ABI

  3. Atherosclerosis

    Peter Libby, Julie E. Buring, Lina Badimón +5

    Sharh maqola20195 iqtibos
    ABI

  4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19

    MaqolaOchiq kirish20225 iqtibos
    ABI

  5. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

    Sharh maqola20153 iqtibos
    ABI

  6. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey

    Željko Reiner, Guy De Backer, Zlatko Fras +4

    Maqola20163 iqtibos
    ABI

  7. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    Guy De Backer, Piotr Jankowski, Kornelia Kotseva +76

    Maqola20193 iqtibos
    ABI

  8. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

    MaqolaOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos
    ABI

  9. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    Alberico L. Catapano, Ian Graham, Guy De Backer +15

    MaqolaOchiq kirish20162 iqtibos
    ABI

  10. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén, M. John Chapman, Ronald M. Krauss +27

    MaqolaOchiq kirish20202 iqtibos
    ABI

  11. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

    Victor Aboyans, Jean‐Baptiste Ricco, Marie-Louise Bartelink +90

    Maqola20172 iqtibos
    ABI

  12. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

    Maqola20232 iqtibos
    ABI

  13. The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms

    Bilge Volkan Salancı, Hakan Aksoy, Pınar Özgen Kıratlı +6

    MaqolaChemotherapy-induced cardiotoxicity and mitigationJournal of Chemotherapy20120 iqtibos
    ABI

  14. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

    Richard Češka, Tomáš Freiberger, Andrey V. Susekov +26

    MaqolaLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos
    ABI

  15. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

    Richard Češka, György Paragh, Željko Reiner +26

    MaqolaOchiq kirishLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos
    ABI

  16. ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey

    D.R. Wood, Catriona Jennings, Kornelia Kotseva +49

    MaqolaOchiq kirish20260 iqtibos
    ABI